Longer-term safety and tolerability of canagliflozin in patients with type 2 diabetes: a pooled analysis.

CONCLUSIONS: Longer-term exposure to canagliflozin as monotherapy or in combination with other agents was generally well tolerated in patients with T2DM. PMID: 27977934 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research